Search research articles
Contact Us
Filters
Showing results (101-110 of 114) with videos related to
Page
of 12
Sort By:
Journal of Medicinal Chemistry
|
January 14, 2000
Disubstituted indazoles as potent antagonists of the integrin alpha(v)beta(3)
D G Batt, J J Petraitis, G C Houghton, et al.
The European Respiratory Journal
|
September 15, 2009
Guidelines for the diagnosis and treatment of pulmonary hypertension
, , , et al.
Bioorganic & Medicinal Chemistry Letters
|
February 19, 2013
Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF-FVIIa inhibitors
Xiaojun Zhang, Peter W Glunz, Wen Jiang, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 17, 2015
Pyridine and pyridinone-based factor XIa inhibitors
James R Corte, Tianan Fang, Jon J Hangeland, et al.
The Oncologist
|
April 2, 2016
Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients
Giovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
The Oncologist
|
November 4, 2016
In Reply
Giovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
Scientific Reports
|
October 29, 2021
Mapping of population disparities in the cholangiocarcinoma urinary metabolome
Munirah Alsaleh, Zoe Leftley, Thomas O'Connor, et al.
Journal of Medicinal Chemistry
|
January 11, 2014
Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors
Mimi L Quan, Pancras C Wong, Cailan Wang, et al.
Journal of Clinical and Experimental Hepatology
|
February 7, 2020
Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort
Munirah Alsaleh, Zoe Leftley, Thomas A Barbera, et al.
British Journal of Cancer
|
April 10, 2014
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer
L Fornaro, S Cereda, G Aprile, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 114) with videos related to
Sort By:
Page
of 12
Journal of Medicinal Chemistry
|
January 14, 2000
Disubstituted indazoles as potent antagonists of the integrin alpha(v)beta(3)
D G Batt, J J Petraitis, G C Houghton, et al.
The European Respiratory Journal
|
September 15, 2009
Guidelines for the diagnosis and treatment of pulmonary hypertension
, , , et al.
Bioorganic & Medicinal Chemistry Letters
|
February 19, 2013
Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF-FVIIa inhibitors
Xiaojun Zhang, Peter W Glunz, Wen Jiang, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 17, 2015
Pyridine and pyridinone-based factor XIa inhibitors
James R Corte, Tianan Fang, Jon J Hangeland, et al.
The Oncologist
|
April 2, 2016
Membrane Localization of Human Equilibrative Nucleoside Transporter 1 in Tumor Cells May Predict Response to Adjuvant Gemcitabine in Resected Cholangiocarcinoma Patients
Giovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
The Oncologist
|
November 4, 2016
In Reply
Giovanni Brandi, Marzia Deserti, Francesco Vasuri, et al.
Scientific Reports
|
October 29, 2021
Mapping of population disparities in the cholangiocarcinoma urinary metabolome
Munirah Alsaleh, Zoe Leftley, Thomas O'Connor, et al.
Journal of Medicinal Chemistry
|
January 11, 2014
Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors
Mimi L Quan, Pancras C Wong, Cailan Wang, et al.
Journal of Clinical and Experimental Hepatology
|
February 7, 2020
Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort
Munirah Alsaleh, Zoe Leftley, Thomas A Barbera, et al.
British Journal of Cancer
|
April 10, 2014
Multivariate prognostic factors analysis for second-line chemotherapy in advanced biliary tract cancer
L Fornaro, S Cereda, G Aprile, et al.
Page
of 12